Kathleen

I, Kathleen Hoffman, nominated by United States of America, residing in United States of America, a member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am employed by Sotera Health as Sr. Vice President of Global Environmental, Health and Safety. My responsibilities include leading the company’s global environmental, health, safety and security management program across the three difference Sotera business units.  Other responsibilities include oversight of various regulatory actions and participation with various government and trade association groups on regulatory and technical topics.  Sotera is a holding company that leads in the contract sterilization and testing services for the medical device and pharmaceutical industries. We utilize ethylene oxide and radiation for the sterilization and bio reduction of medical products, cosmetics and food products.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following
   • Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces).
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: See response to #2.
   • Government advice and other policy development: See response to #2.
   • Paid research activities, fellowships or grants:  None
   • Other interests:  None
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is by a voluntary basis.  However, such funding is very limited because my participation is mainly done on a remote basis.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have declined to disclose information falling within paragraph 10 of those Guidelines and I undertake to ensure that I am completely excluded from discussion and decisions on topics related to the information that I have declined to disclose. 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name:             Kathleen Hoffman
Date:               April 21, 2021